The Institute of Science and Technology Austria (ISTA) invites journalists to apply for its annual, generously funded ...

IRVINE, Calif., Sept. 16 /PRNewswire/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced that it has initiated a Phase 3 clinical program of ISTA's proprietary formulation of REMURA TM ...

The Institute of Science and Technology Austria (ISTA) is offering science journalists the opportunity for a paid three-month "Journalist in Residence“ program starting in April 2024. Applications are ...

The Institute of Science and Technology Austria (ISTA) is offering science journalists the opportunity for a paid three-month “Journalist in Residence” program starting in April 2024. Applications are ...

IRVINE, Calif., Sept. 16 ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced that it has initiated a Phase 3 clinical program of ISTA's proprietary formulation of REMURA(TM) (bromfenac ...

IRVINE, Calif. — Ista Pharmaceuticals initiated a new phase 3 program designed to evaluate its proprietary formulation of Remura dry eye solution, the company announced in a press release. Ista will ...

ISTA Pharmaceuticals Reports Results From the Second of Two Studies in the REMURA(TM) Phase 3 Clinical Program for Dry Eye Disease IRVINE, CA, Oct 13, 2011 (MARKETWIRE via COMTEX) -- ISTA ...

ISTA Pharmaceuticals, Inc. has announced top-line results from the first of its two Phase 3 studies to evaluate the short-term safety and efficacy of two concentrations of REMURA™ (bromfenac ...

INDIANAPOLIS — The Indiana State Teachers Association and its parent organization have agreed to a proposed $14 million settlement with 27 Indiana school districts to resolve Indiana regulators’ ...